Tularemia_NN Francisella_NP tularensis_NN is_VBZ the_DT etiological_JJ agent_NN of_IN tularemia_NN ,_, a_DT serious_JJ and_CC occasionally_RB fatal_JJ disease_NN of_IN humans_NNS and_CC animals_NNS ._SENT In_IN humans_NNS ,_, ulceroglandular_JJ tularemia_NN is_VBZ the_DT most_RBS common_JJ form_NN of_IN the_DT disease_NN and_CC is_VBZ usually_RB a_DT consequence_NN of_IN a_DT bite_NN from_IN an_DT arthropod_NN vector_NN which_WDT has_VBZ previously_RB fed_VBN on_IN an_DT infected_JJ animal_NN ._SENT The_DT pneumonic_JJ form_NN of_IN the_DT disease_NN occurs_VBZ rarely_RB but_CC is_VBZ the_DT likely_JJ form_NN of_IN the_DT disease_NN should_MD this_DT bacterium_NN be_VB used_VBN as_IN a_DT bioterrorism_NN agent_NN ._SENT The_DT diagnosis_NN of_IN disease_NN is_VBZ not_RB straightforward_JJ ._SENT F._NP tularensis_NN is_VBZ difficult_JJ to_TO culture_NN ,_, and_CC the_DT handling_NN of_IN this_DT bacterium_NN poses_VBZ a_DT significant_JJ risk_NN of_IN infection_NN to_TO laboratory_NN personnel_NNS ._SENT Enzyme-linked_JJ immunosorbent_JJ assay-_NN and_CC PCR-based_JJ methods_NNS have_VBP been_VBN used_VBN to_TO detect_VB bacteria_NNS in_IN clinical_JJ samples_NNS ,_, but_CC these_DT methods_NNS have_VBP not_RB been_VBN adequately_RB evaluated_VBN for_IN the_DT diagnosis_NN of_IN pneumonic_JJ tularemia_NN ._SENT Little_RB is_VBZ known_VBN about_IN the_DT virulence_NN mechanisms_NNS of_IN F._NP tularensis_NN ,_, though_IN there_EX is_VBZ a_DT large_JJ body_NN of_IN evidence_NN indicating_VBG that_IN it_PP is_VBZ an_DT intracellular_JJ pathogen_NN ,_, surviving_VBG mainly_RB in_IN macrophages_NNS ._SENT An_DT unlicensed_JJ live_JJ attenuated_JJ vaccine_NN is_VBZ available_JJ ,_, which_WDT does_VBZ appear_VB to_TO offer_VB protection_NN against_IN ulceroglandular_JJ and_CC pneumonic_JJ tularemia_NN ._SENT Although_IN an_DT improved_VBN vaccine_NN against_IN tularemia_NN is_VBZ highly_RB desirable_JJ ,_, attempts_VBZ to_TO devise_VB such_PDT a_DT vaccine_NN have_VBP been_VBN limited_VBN by_IN the_DT inability_NN to_TO construct_VB defined_VBN allelic_JJ replacement_NN mutants_NNS and_CC by_IN the_DT lack_NN of_IN information_NN on_IN the_DT mechanisms_NNS of_IN virulence_NN of_IN F._NP tularensis_NN ._SENT In_IN the_DT absence_NN of_IN a_DT licensed_JJ vaccine_NN ,_, aminoglycoside_NN antibiotics_NNS play_VBP a_DT key_JJ role_NN in_IN the_DT prevention_NN and_CC treatment_NN of_IN tularemia_NN ._SENT In_IN 1911_CD ,_, an_DT outbreak_NN of_IN a_DT plague-like_JJ disease_NN in_IN rodents_NNS in_IN Tulare_NP County_NP ,_, California_NP ,_, provided_VBD the_DT first_JJ isolation_NN of_IN a_DT small_JJ gram-negative_JJ bacterium_NN which_WDT was_VBD named_VBN Bacterium_NN tularensis_NN ._SENT Subsequently_RB ,_, natural_JJ infections_NNS with_IN Francisella_NP tularensis_NNS have_VBP been_VBN reported_VBN in_IN a_DT range_NN of_IN vertebrates_NNS including_VBG mammals_NNS ,_, birds_NNS ,_, amphibians_NNS ,_, and_CC fish_NN ,_, and_CC even_RB in_IN invertebrates_NNS ._SENT Tularemia_NN occurs_VBZ only_RB in_IN the_DT northern_JJ hemisphere_NN and_CC most_RBS frequently_RB in_IN Scandinavia_NP ,_, northern_JJ America_NP ,_, Japan_NP ,_, and_CC Russia_NP ._SENT However_RB ,_, tularemia_NN has_VBZ recently_RB been_VBN reported_VBN from_IN Turkey_NP ,_, Yugoslavia_NP ,_, Spain_NP ,_, Kosovo_NP ,_, and_CC Switzerland_NP ,_, indicating_VBG that_IN tularemia_NN is_VBZ even_RB more_RBR widely_RB distributed_VBD than_IN was_VBD previously_RB thought_VBN ._SENT In_IN many_JJ parts_NNS of_IN the_DT world_NN ,_, colloquial_JJ names_NNS such_JJ as_IN rabbit_NN fever_NN ,_, hare_NN fever_NN ,_, deerfly_NN fever_NN ,_, and_CC lemming_NN fever_NN have_VBP been_VBN used_VBN to_TO describe_VB the_DT disease_NN ._SENT Tularemia_NN is_VBZ not_RB a_DT disease_NN which_WDT is_VBZ notifiable_JJ to_TO the_DT World_NP Health_NP Organization_NP ,_, and_CC the_DT worldwide_JJ incidence_NN of_IN disease_NN is_VBZ not_RB known_VBN ._SENT Nevertheless_RB ,_, some_DT data_NNS on_IN the_DT incidence_NN of_IN disease_NN are_VBP available_JJ ._SENT In_IN Sweden_NP ,_, the_DT annual_JJ number_NN of_IN reported_VBN cases_NNS of_IN disease_NN in_IN humans_NNS over_IN the_DT period_NN from_IN 1973_CD to_TO 1985_CD ranged_VBN from_IN less_JJR than_IN 5_CD cases_NNS to_TO over_RB 500_CD ._SENT In_IN Japan_NP 1,355_CD cases_NNS of_IN tularemia_NN were_VBD reported_VBN over_IN the_DT period_NN 1924_CD to_TO 1987_CD ._SENT In_IN Turkey_NP ,_, 205_CD cases_NNS were_VBD reported_VBN over_IN the_DT period_NN 1988_CD to_TO 1998_CD ,_, while_IN in_IN Slovakia_NP 126_CD cases_NNS of_IN disease_NN were_VBD reported_VBN during_IN the_DT period_NN 1985_CD to_TO 1994_CD ._SENT In_IN some_DT parts_NNS of_IN the_DT world_NN ,_, the_DT number_NN of_IN cases_NNS of_IN tularemia_NN has_VBZ declined_VBN markedly_RB during_IN the_DT twentieth_JJ century_NN :_: in_IN the_DT United_NP States_NPS ,_, the_DT annual_JJ number_NN of_IN reported_VBN cases_NNS of_IN tularemia_NN declined_VBD from_IN several_JJ thousand_CD in_IN the_DT 1930s_NNS to_TO several_JJ hundred_CD in_IN the_DT 1980s_NNS ._SENT It_PP is_VBZ likely_JJ that_IN these_DT figures_NNS are_VBP a_DT gross_JJ underrepresentation_NN of_IN the_DT true_JJ incidence_NN of_IN tularemia_NN ,_, because_IN many_JJ infections_NNS are_VBP not_RB diagnosed_VBN as_IN a_DT consequence_NN of_IN the_DT relatively_RB benign_JJ nature_NN of_IN disease_NN caused_VBN by_IN some_DT strains_NNS of_IN F._NP tularensis_NN and_CC by_IN some_DT difficulties_NNS in_IN laboratory_NN testing_NN ._SENT F._NP tularensis_NN has_VBZ been_VBN an_DT organism_NN of_IN concern_NN as_IN a_DT biological_JJ threat_NN agent_NN since_IN the_DT large_JJ state-funded_JJ biological_JJ weapons_NNS programs_NNS of_IN the_DT 1950s_NNS ,_, when_WRB the_DT United_NP States_NPS first_RB evaluated_VBD the_DT organism_NN as_IN a_DT biological_JJ weapon_NN ,_, and_CC it_PP was_VBD subsequently_RB incorporated_VBN into_IN weapons_NNS by_IN the_DT U.S.S.R._NP (_( reviewed_VBN in_IN reference_NN )_) ._SENT Now_RB that_IN the_DT emphasis_NN has_VBZ shifted_VBN towards_IN defending_VBG against_IN biological_JJ terrorism_NN ,_, public_JJ health_NN and_CC medical_JJ management_NN protocols_NNS following_VBG a_DT release_NN of_IN tularemia_NN have_VBP been_VBN reviewed_VBN ._SENT FIG._NN 1_CD ._SENT |_SYM World_NP map_NN showing_VBG areas_NNS where_WRB F._NP tularensis_NN World_NP map_NN showing_VBG areas_NNS where_WRB F._NP tularensis_NN is_VBZ endemic_JJ (_( shaded_JJ )_) ._SENT F._NP tularensis_NN is_VBZ thought_VBN to_TO be_VB maintained_VBN in_IN the_DT environment_NN principally_RB by_IN various_JJ terrestrial_JJ and_CC aquatic_JJ mammals_NNS such_JJ as_IN ground_NN squirrels_NNS ,_, rabbits_NNS ,_, hares_NNS ,_, voles_NNS ,_, muskrats_NNS ,_, water_NN rats_NNS ,_, and_CC other_JJ rodents_NNS ._SENT In_IN regions_NNS where_WRB tularemia_NN is_VBZ endemic_JJ ,_, antibodies_NNS to_TO F._NP tularensis_NNS are_VBP frequently_RB detected_VBN in_IN the_DT sera_NN of_IN trapped_JJ wild_JJ animals_NNS ._SENT Outbreaks_NNS of_IN disease_NN in_IN humans_NNS often_RB parallel_JJ outbreaks_NNS of_IN tularemia_NN in_IN wild_JJ animals_NNS ._SENT For_IN example_NN ,_, in_IN Sweden_NP a_DT clear_JJ correlation_NN between_IN peaks_NNS in_IN vole_NN and_CC hare_NN populations_NNS and_CC outbreaks_NNS of_IN tularemia_NN in_IN humans_NNS have_VBP been_VBN reported_VBN ,_, and_CC outbreaks_NNS of_IN tularemia_NN in_IN humans_NNS in_IN the_DT former_JJ Soviet_NP Union_NP have_VBP been_VBN linked_VBN to_TO epizootics_NNS of_IN disease_NN in_IN ground_NN voles_NNS ._SENT However_RB ,_, it_PP is_VBZ not_RB clear_JJ whether_IN these_DT animal_JJ species_NNS are_VBP the_DT true_JJ reservoir_NN of_IN the_DT bacterium_NN in_IN the_DT environment_NN ._SENT A_DT wide_JJ range_NN of_IN arthropod_NN vectors_NNS have_VBP also_RB been_VBN implicated_VBN in_IN the_DT transmission_NN of_IN tularemia_NN between_IN mammalian_JJ hosts_NNS ._SENT In_IN central_JJ Europe_NP ,_, the_DT ticks_VBZ Dermacentor_NP reticulatus_NP and_CC Ixodes_NP ricinus_NNS are_VBP important_JJ vectors_NNS ._SENT In_IN areas_NNS of_IN the_DT Czech_NP Republic_NP and_CC Austria_NP where_WRB natural_JJ foci_NNS of_IN tularemia_NN occur_VBP ,_, between_IN 2.1_CD and_CC 2.8_CD %_NN of_IN D._NP reticulatus_NN ticks_NNS analyzed_VBD contained_VBN F._NP tularensis_NN ._SENT In_IN the_DT United_NP States_NPS ,_, biting_VBG flies_NNS are_VBP the_DT most_RBS common_JJ vectors_NNS in_IN Utah_NP ,_, Nevada_NP ,_, and_CC California_NP ,_, while_IN ticks_NNS are_VBP the_DT most_RBS important_JJ vectors_NNS east_JJ of_IN the_DT Rocky_NP Mountains_NP ._SENT In_IN the_DT former_JJ Soviet_NP Union_NP ,_, the_DT bacterium_NN is_VBZ transmitted_VBN by_IN both_DT mosquitoes_NNS (_( Aedes_NP ,_, Culex_NP ,_, and_CC Anopheles_NP species_NNS )_) and_CC the_DT Ixodes_NP species_NN of_IN tick_NN ._SENT Such_JJ arthropod_NN vectors_NNS play_VBP a_DT role_NN both_CC in_IN the_DT transmission_NN of_IN the_DT disease_NN within_IN wild_JJ animal_NN populations_NNS and_CC in_IN the_DT transmission_NN of_IN disease_NN to_TO humans_NNS ._SENT It_PP therefore_RB follows_VBZ that_IN rural_JJ populations_NNS ,_, especially_RB individuals_NNS who_WP spend_VBP time_NN in_IN endemic_JJ areas_NNS such_JJ as_IN farmers_NNS ,_, hunters_NNS ,_, walkers_NNS ,_, and_CC forest_NN workers_NNS ,_, are_VBP most_RBS at_IN risk_NN of_IN contracting_NN tularemia_NN ._SENT There_EX is_VBZ evidence_NN that_IN the_DT bacterium_NN can_MD persist_VB in_IN watercourses_NNS ,_, possibly_RB in_IN association_NN with_IN amoebae_NNS ._SENT Beavers_NNS and_CC muskrats_NNS in_IN North_NP America_NP and_CC lemmings_NNS and_CC beavers_NNS in_IN Scandinavia_NP might_MD also_RB play_VB a_DT role_NN in_IN the_DT maintenance_NN of_IN the_DT bacterium_NN in_IN watercourses_NNS ._SENT During_IN a_DT prolonged_JJ period_NN in_IN water_NN (_( 140_CD days_NNS in_IN the_DT study_NN reported_VBD )_) ,_, the_DT number_NN of_IN directly_RB culturable_JJ bacterial_JJ cells_NNS declined_VBD to_TO below_IN detectable_JJ levels_NNS ._SENT However_RB ,_, on_IN the_DT basis_NN of_IN rhodamine_NN 123_CD staining_VBG ,_, which_WDT is_VBZ indicative_JJ of_IN metabolic_JJ activity_NN ,_, at_IN least_JJS 30_CD %_NN of_IN these_DT cells_NNS were_VBD judged_VBN to_TO be_VB viable_JJ ._SENT Although_IN this_DT finding_NN suggests_VBZ that_IN F._NP tularensis_NN can_MD persist_VB in_IN a_DT viable_JJ but_CC nonculturable_JJ form_NN in_IN water_NN ,_, the_DT bacteria_NNS were_VBD not_RB able_JJ to_TO cause_VB disease_NN when_WRB injected_VBN into_IN mice_NNS ._SENT These_DT findings_NNS might_MD have_VB implications_NNS for_IN techniques_NNS which_WDT rely_VBP on_IN the_DT direct_JJ culture_NN of_IN F._NP tularensis_NN to_TO identify_VB bacteria_NNS in_IN watercourses_NNS ._SENT The_DT taxonomic_JJ position_NN of_IN F._NP tularensis_NN is_VBZ complex_JJ and_CC has_VBZ changed_VBN frequently_RB ._SENT F._NP tularensis_NN was_VBD originally_RB included_VBN in_IN the_DT genus_NN Bacterium_NN ,_, later_RBR in_IN the_DT Pasteurella_NP genus_NN ,_, and_CC subsequently_RB provisionally_RB placed_VBN in_IN the_DT Brucella_NP genus_NN ._SENT In_IN 1947_CD ,_, the_DT proposal_NN was_VBD made_VBN that_IN the_DT bacterium_NN should_MD be_VB the_DT sole_JJ member_NN of_IN a_DT new_JJ genus_NN called_VBN Francisella_NP ._SENT The_DT most_RBS recent_JJ issue_NN of_IN Bergey_NP 's_POS Manual_NP of_IN Systematic_NP Bacteriology_NP indicates_VBZ that_IN F._NP tularensis_NN and_CC F._NP novicida_NNS are_VBP the_DT two_CD species_NNS in_IN the_DT genus_NN Francisella_NP ._SENT F._NP novicida_NP has_VBZ been_VBN differentiated_VBN on_IN the_DT basis_NN of_IN inability_NN to_TO produce_VB acid_NN from_IN sucrose_NN ,_, the_DT relative_JJ ease_NN of_IN culture_NN ,_, and_CC the_DT lack_NN of_IN virulence_NN for_IN humans_NNS and_CC rabbits_NNS ._SENT However_RB ,_, several_JJ workers_NNS have_VBP since_RB questioned_VBN whether_IN F._NP novicida_NN should_MD be_VB considered_VBN a_DT separate_JJ species_NN ._SENT F._NP novicida_NP is_VBZ now_RB known_VBN to_TO be_VB capable_JJ of_IN causing_VBG a_DT tularemia-like_JJ illness_NN in_IN humans_NNS ,_, and_CC on_IN the_DT basis_NN of_IN DNA_NN hybridization_NN ,_, F._NP novicida_NNS was_VBD not_RB distinguishable_JJ from_IN F._NP tularensis_NN ._SENT More_RBR recently_RB ,_, the_DT 16S_JJ ribosomal_JJ DNA_NN (_( rDNA_NN )_) sequences_NNS of_IN F._NP tularensis_NN and_CC F._NP novicida_NNS have_VBP been_VBN shown_VBN to_TO have_VB a_DT high_JJ degree_NN of_IN sequence_NN similarity_NN (_( 99.6_CD %_NN )_) ._SENT On_IN the_DT basis_NN of_IN these_DT studies_NNS ,_, both_CC Hollis_NN et_FW al._FW and_CC Forsman_NP et_FW al._FW proposed_VBN that_IN F._NP novicida_NNS should_MD be_VB considered_VBN a_DT subspecies_NN of_IN F._NP tularensis_NN ._SENT More_RBR recently_RB ,_, a_DT detailed_JJ analysis_NN of_IN several_JJ strains_NNS of_IN Yersinia_NP philomiragia_NNS revealed_VBD their_PP$ fatty_JJ acid_NN compositions_NNS to_TO be_VB typical_JJ of_IN the_DT genus_NN Francisella_NP ._SENT In_IN addition_NN ,_, the_DT DNA_NN from_IN these_DT strains_NNS showed_VBD a_DT high_JJ degree_NN of_IN relatedness_NN to_TO F._NP tularensis_NN DNA_NN ._SENT These_DT observations_NNS indicated_VBD that_IN Y._NP philomiragia_NNS should_MD be_VB included_VBN in_IN the_DT Francisella_NP genus_NN and_CC renamed_VBD Francisellaphilomiragia_NP ._SENT This_DT proposal_NN is_VBZ supported_VBN by_IN the_DT finding_NN that_IN the_DT 16S_JJ rDNA_NN sequences_NNS of_IN F._NP tularensis_NN and_CC F._NP philomiragia_NNS confirm_VBP both_DT its_PP$ placement_NN in_IN the_DT Francisella_NP genus_NN and_CC its_PP$ identity_NN as_IN a_DT separate_JJ species_NN ._SENT F._NP philomiragia_NN strains_NNS can_MD also_RB be_VB distinguished_VBN from_IN F._NP tularensis_NN because_IN the_DT former_JJ are_VBP oxidase_NN positive_JJ in_IN the_DT Kovacs_NP modification_NN of_IN this_DT test_NN ,_, are_VBP often_RB able_JJ to_TO hydrolyze_VB gelatin_NN ,_, and_CC are_VBP relatively_RB easily_RB cultured_VBN ._SENT In_IN addition_NN ,_, F._NP philomiragia_NN is_VBZ considered_VBN virulent_JJ only_RB in_IN immunocompromised_JJ individuals_NNS or_CC in_IN those_DT who_WP have_VBP recently_RB had_VBN a_DT near-drowning_NN experience_NN ._SENT Therefore_RB ,_, the_DT current_JJ consensus_NN position_NN appears_VBZ to_TO be_VB that_DT F._NP tularensis_NN and_CC F._NP philomiragia_NNS are_VBP the_DT sole_JJ members_NNS of_IN the_DT Francisella_NP genus_NN within_IN the_DT Francisellaceae_NP family_NN ._SENT The_DT 16S_JJ rDNA_NN sequences_NNS of_IN the_DT members_NNS of_IN this_DT family_NN contain_VBP the_DT consensus_NN sequence_NN for_IN members_NNS of_IN the_DT gamma-subclass_NN of_IN Proteobacteria_NP ._SENT This_DT family_NN also_RB includes_VBZ Wolbachia_NP persica_NP ,_, a_DT parasite_NN of_IN arthropods_NNS and_CC worms_NNS ,_, the_DT Dermacentor_NP andersoni_NN symbiont_NN ,_, which_WDT was_VBD originally_RB isolated_VBN from_IN Rocky_NP Mountain_NP wood_NN ticks_NNS ,_, and_CC Ornithodorous_JJ moubata_NN symbiont_NN B_NN ._SENT Most_JJS of_IN these_DT arthropod_NN endosymbionts_NNS are_VBP poorly_RB characterized_VBN ._SENT However_RB ,_, W._NP persica_NP is_VBZ known_VBN to_TO exist_VB in_IN the_DT Malpighian_JJ tubules_NNS of_IN the_DT soft_JJ tick_NN Argas_NP arboreus_NN and_CC is_VBZ not_RB considered_VBN a_DT pathogen_NN of_IN mammals_NNS ._SENT For_IN F._NP tularensis_NN ,_, several_JJ subspecies_NN other_JJ than_IN novicida_NNS have_VBP been_VBN proposed_VBN ._SENT Originally_RB ,_, F._NP tularensis_NN strains_NNS were_VBD identified_VBN as_IN belonging_VBG to_TO either_DT subsp_NN ._SENT tularensis_NN (_( also_RB known_VBN as_IN type_NN A_DT or_CC subspecies_NN nearctica_NN )_) or_CC subspecies_NN palaearctica_NN (_( also_RB know_VB as_IN type_NN B_NN or_CC subspecies_NN holarctica_NNS )_) principally_RB on_IN the_DT basis_NN of_IN virulence_NN ,_, citrulline_NN ureidase_NN activity_NN (_( conversion_NN of_IN l-citrulline_NN to_TO ornithine_NN )_) ,_, and_CC acid_JJ production_NN from_IN glycerol_NN ._SENT Subspecies_NN holarctica_NN is_VBZ now_RB the_DT most_RBS widely_RB used_VBN terminology_NN in_IN place_NN of_IN subspecies_NN palaearctica_NN ._SENT A_DT more_RBR detailed_JJ description_NN of_IN the_DT properties_NNS of_IN subsp_NN ._SENT tularensis_NN and_CC subspecies_NN holarctica_NN can_MD be_VB found_VBN in_IN Olsufjev_NP and_CC Mesheryakova_NP ._SENT Three_CD biovars_NNS of_IN F._NP tularensis_NN subspecies_NN holarctica_NNS have_VBP been_VBN suggested_VBN ;_: biovar_NN I_PP (_( erythromycin_NN sensitive_JJ )_) ,_, biovar_NP II_NP (_( erythromycin_NN resistant_NN )_) ,_, and_CC biovar_JJ japonica_NN ._SENT Strains_NNS of_IN F._NP tularensis_NN subsp_NN ._SENT tularensis_NNS are_VBP considered_VBN the_DT most_RBS virulent_JJ for_IN humans_NNS ,_, with_IN an_DT infectious_JJ dose_NN of_IN less_JJR than_IN 10_CD CFU_NP and_CC a_DT mortality_NN of_IN 5_CD to_TO 6_CD %_NN in_IN untreated_JJ cases_NNS of_IN cutaneous_JJ disease_NN ._SENT F._NP tularensis_NN strain_NN Schu_NP S4_NP is_VBZ the_DT proposed_VBN subsp_NN ._SENT tularensis_NN type_NN strain_NN ._SENT Strains_NNS of_IN subspecies_NN holarctica_NNS do_VBP not_RB cause_VB disease_NN in_IN rabbits_NNS ,_, and_CC the_DT mortality_NN rate_NN associated_VBN with_IN cutaneous_JJ disease_NN in_IN humans_NNS is_VBZ less_JJR than_IN 0.5_CD %_NN ._SENT Until_IN recently_RB ,_, F._NP tularensis_NN subsp_NN ._SENT tularensis_NN was_VBD thought_VBN to_TO be_VB found_VBN only_RB in_IN North_NP America_NP ._SENT However_RB ,_, the_DT recent_JJ isolation_NN of_IN this_DT subspecies_NN in_IN Europe_NP suggests_VBZ that_IN it_PP may_MD be_VB more_JJR widely_RB distributed_VBD than_IN was_VBD previously_RB thought_VBN ._SENT F._NP tularensis_NN subspecies_NN holarctica_NN is_VBZ found_VBN mainly_RB in_IN North_NP America_NP and_CC in_IN Eurasia_NP ._SENT A_DT fourth_JJ subspecies_NN ,_, F._NP tularensis_NN subsp_NN ._SENT mediaasiatica_NP ,_, is_VBZ found_VBN predominantly_RB in_IN the_DT central_JJ Asian_JJ republics_NNS of_IN the_DT former_JJ USSR_NN ._SENT These_DT strains_NNS possess_VBP citrulline_NN ureidase_NN activity_NN and_CC are_VBP able_JJ to_TO ferment_VB glycerol_NN ,_, but_CC are_VBP less_RBR virulent_JJ than_IN strains_NNS of_IN F._NP tularensis_NN subsp_NN ._SENT tularensis_NN in_IN rabbits_NNS ._SENT FIG._NN 2_CD ._SENT |_SYM Evolutionary_NP distance_NN tree_NN ,_, based_VBN on_IN 16S_JJ rDNA_NN sequences_NNS ,_, showing_VBG the_DT relationship_NN of_IN F._NP tularensis_NN Evolutionary_NP distance_NN tree_NN ,_, based_VBN on_IN 16S_JJ rDNA_NN sequences_NNS ,_, showing_VBG the_DT relationship_NN of_IN F._NP tularensis_NN with_IN other_JJ putative_JJ members_NNS of_IN the_DT Francisellaceae_NP and_CC with_IN other_JJ closely_RB related_VBN members_NNS of_IN the_DT gamma_NN subclass_NN of_IN the_DT Proteobacteria_NP ._SENT Agrobacterium_NN tumefaciens_NNS was_VBD included_VBN as_IN an_DT outgroup_NN ._SENT Reproduced_VBN from_IN Forsman_NP et_FW al._FW with_IN the_DT kind_NN permission_NN of_IN the_DT International_NP Union_NP of_IN Microbiological_NP Societies_NP ._SENT TABLE_NN 1_CD |_SYM Taxonomy_NN and_CC characteristics_NNS of_IN the_DT subspecies_NN of_IN F._NP tularensis_NN The_DT genetic_JJ makeup_NN of_IN F._NP tularensis_NN is_VBZ poorly_RB understood_VBN ,_, with_IN sequences_NNS of_IN only_RB 34_CD genes_NNS deposited_VBN with_IN GenBank_NP ._SENT Two_CD different_JJ cryptic_JJ plasmids_NNS (_( pOM1_JJ and_CC pNFL10_JJ )_) are_VBP reportedly_RB found_VBN in_IN the_DT live_JJ vaccine_NN strain_NN (_( LVS_NP )_) and_CC in_IN F._NP novicida_NN ,_, respectively_RB (_( GenBank_NP accession_NN AFO55345_NP )_) ._SENT This_DT paucity_NN of_IN information_NN has_VBZ prompted_VBN two_CD projects_NNS to_TO sequence_NN the_DT F._NP tularensis_NN genome_NN ._SENT The_DT genome_NN sequence_NN of_IN a_DT strain_NN of_IN F._NP tularensis_NN subsp_NN ._SENT tularensis_NN (_( strain_NN Schu_NP S4_NP )_) is_VBZ currently_RB being_VBG determined_VBN by_IN a_DT consortium_NN of_IN laboratories_NNS in_IN Europe_NP and_CC the_DT United_NP States_NPS ._SENT A_DT project_NN to_TO sequence_NN the_DT genome_NN of_IN LVS_NP ,_, originally_RB derived_VBN from_IN a_DT virulent_JJ F._NP tularensis_NN subsp_NN ._SENT holarctica_NN strain_NN ,_, has_VBZ recently_RB commenced_VBN in_IN the_DT United_NP States_NPS ._SENT Preliminary_JJ results_NNS from_IN the_DT strain_NN Schu_NP S4_NP genome_NN sequencing_VBG project_NN suggest_VBP a_DT total_JJ genome_NN size_NN of_IN <2_JJ Mbp_NP ,_, making_VBG this_DT one_CD of_IN the_DT smaller_JJR bacterial_JJ genomes_NNS ._SENT Strain_NP Schu_NP S4_NP does_VBZ not_RB appear_VB to_TO possess_VB either_DT plasmid_NN pOM1_NN or_CC pNFL10_NN ._SENT The_DT G+C_NP content_NN of_IN the_DT genome_NN is_VBZ approximately_RB 34_CD %_NN ._SENT A_DT preliminary_JJ annotation_NN has_VBZ identified_VBN 1,804_CD candidate_NN open_JJ reading_NN frames_NNS which_WDT are_VBP characterized_VBN by_IN a_DT slight_JJ shift_NN in_IN G+C_NP content_NN ._SENT Of_IN these_DT ,_, 1,289_CD are_VBP thought_VBN to_TO encode_VB proteins_NNS ,_, of_IN which_WDT 413_CD had_VBD no_DT database_NN match_NN ,_, meaning_VBG that_IN in_IN comparison_NN with_IN many_JJ other_JJ bacterial_JJ genomes_NNS ,_, F._NP tularensis_NN contains_VBZ a_DT high_JJ proportion_NN of_IN unique_JJ genes_NNS ._SENT On_IN the_DT basis_NN of_IN database_NN matches_NNS with_IN known_VBN proteins_NNS ,_, genes_NNS encoding_VBG putative_JJ transport/binding_NN ,_, gene_NN regulation_NN ,_, energy_NN metabolism_NN ,_, and_CC cellular_JJ processes_NNS appeared_VBD to_TO be_VB underrepresented_VBN in_IN the_DT F._NP tularensis_NN genome_NN ._SENT FIG._NN 3_CD ._SENT |_SYM Preliminary_JJ annotation_NN of_IN the_DT F._NP tularensis_NN Preliminary_JJ annotation_NN of_IN the_DT F._NP tularensis_NN strain_NN Schu_NP S4_NP genome_NN sequence_NN ;_: comparison_NN of_IN the_DT number_NN of_IN F._NP tularensis_NN genes_NNS in_IN 15_CD functional_JJ categories_NNS (_( solid_JJ bars_NNS )_) ._SENT The_DT mean_JJ number_NN of_IN genes_NNS in_IN these_DT categories_NNS in_IN 20_CD other_JJ bacterial_JJ species_NN is_VBZ shown_VBN as_IN open_JJ bars_NNS ,_, with_IN error_NN bars_NNS indicating_VBG the_DT lowest_JJS and_CC highest_JJS numbers_NNS of_IN genes_NNS in_IN each_DT category_NN ._SENT Reproduced_VBN from_IN Prior_RB et_FW al._FW with_IN the_DT kind_NN permission_NN of_IN Blackwell_NP Scientific_NP Limited_NP ._SENT F._NP tularensis_NN is_VBZ a_DT fastidious_JJ organism_NN which_WDT requires_VBZ enriched_VBN medium_NN for_IN growth_NN ._SENT Traditionally_RB ,_, cysteine_NN glucose_NN blood_NN agar_NN has_VBZ been_VBN the_DT growth_NN medium_NN of_IN choice_NN ._SENT However_RB ,_, enriched_VBD chocolate_NN agar_NN (_( cysteine_NN heart_NN agar_NN supplemented_VBN with_IN 9_CD %_NN heated_JJ sheep_NN red_JJ blood_NN cells_NNS [_SYM CHAB_NP ]_SYM )_) and_CC nonselective_JJ buffered_VBN charcoal_NN yeast_NN extract_NN agar_NN also_RB support_VB the_DT growth_NN of_IN the_DT organism_NN and_CC may_MD be_VB used_VBN for_IN isolation_NN ._SENT The_DT Centers_NPS for_IN Disease_NP Control_NP and_CC Prevention_NP guidelines_NNS recommend_VBP the_DT use_NN of_IN CHAB_NP once_IN growth_NN on_IN the_DT general_JJ microbiological_JJ agars_NNS ,_, such_JJ as_IN sheep_NN blood_NN agar_NN ,_, chocolate_NN agar_NN ,_, and_CC Thayer-Martin_NP agar_NN ,_, which_WDT are_VBP routinely_RB used_VBN in_IN U.S._NP laboratories_NNS for_IN the_DT isolation_NN of_IN bacteria_NNS from_IN clinical_JJ specimens_NNS ,_, indicates_VBZ the_DT pathogen_NN to_TO be_VB present_JJ ._SENT A_DT heavy_JJ inoculum_NN on_IN appropriate_JJ medium_NN will_MD yield_VB visible_JJ growth_NN in_IN 18_CD h_NN ,_, but_CC the_DT appearance_NN of_IN individual_JJ colonies_NNS may_MD require_VB 2_CD to_TO 4_CD days_NNS of_IN incubation_NN ._SENT F._NP tularensis_NN grows_VBZ slowly_RB at_IN 37C_JJ and_CC poorly_RB at_IN 28C_JJ ,_, and_CC this_DT can_MD be_VB exploited_VBN to_TO distinguish_VB F._NP tularensis_NN from_IN Yersinia_NP pestis_NP ,_, F._NP philomiragia_NNS ,_, and_CC F._NP tularensis_NN subsp_NN ._SENT novicida_NN ,_, all_DT of_IN which_WDT grow_VBP well_RB at_IN 28C_JJ ._SENT On_IN CHAB_NP ,_, colonies_NNS are_VBP 2_CD to_TO 4_CD mm_NN in_IN size_NN ,_, greenish-white_JJ ,_, round_JJ ,_, smooth_JJ ,_, and_CC slightly_RB mucoid_JJ ,_, while_IN on_IN media_NNS containing_VBG whole_JJ blood_NN there_EX is_VBZ usually_RB a_DT small_JJ zone_NN of_IN alpha-hemolysis_NN surrounding_VBG colonies_NNS ._SENT Gram_NN staining_VBG of_IN cultured_JJ material_NN reveals_VBZ small_JJ (_( 0.2_CD to_TO 0.5_CD mum_NN by_IN 0.7_CD to_TO 1.0_CD mum_NN )_) ,_, mainly_RB single_JJ gram-negative_JJ coccobacilli_NNS which_WDT stain_VBP weakly_RB ._SENT Chemically_RB defined_VBN media_NNS capable_JJ of_IN supporting_VBG the_DT growth_NN of_IN F._NP tularensis_NNS do_VBP exist_VB ,_, but_CC growth_NN on_IN such_JJ media_NNS is_VBZ slower_JJR and_CC the_DT colonies_NNS are_VBP smaller_JJR than_IN on_IN traditional_JJ rich_JJ agars_NNS ._SENT F._NP tularensis_NN does_VBZ not_RB grow_VB well_RB in_IN liquid_JJ media_NNS even_RB when_WRB the_DT medium_NN is_VBZ supplemented_VBN with_IN cysteine_NN and_CC requires_VBZ a_DT large_JJ inoculum_NN to_TO obtain_VB visible_JJ growth_NN within_IN 24_CD h._JJ Clinical_JJ laboratories_NNS routinely_RB inoculate_VBP clinical_JJ specimens_NNS into_IN broth_NN ,_, usually_RB brain_NN heart_NN infusion_NN or_CC Trypticase_NN soy_NN broth_NN ,_, for_IN the_DT recovery_NN of_IN bacteria_NNS ._SENT However_RB ,_, F._NP tularensis_NN requires_VBZ enriched_VBN media_NNS for_IN growth_NN ,_, supplemented_VBN with_IN cysteine_NN ._SENT The_DT organism_NN has_VBZ been_VBN cultivated_VBN in_IN modified_JJ Mueller-Hinton_NP broth_NN and_CC thioglycollate_NN broth_NN ._SENT In_IN Mueller-Hinton_NP broth_NN ,_, the_DT addition_NN of_IN 0.025_CD %_NN ferric_JJ pyrophosphate_NN appeared_VBD to_TO enhance_VB the_DT growth_NN of_IN F._NP tularensis_NN ._SENT Growth_NN in_IN liquid_JJ media_NNS is_VBZ slow_JJ ,_, requiring_VBG up_RB 3_CD to_TO 7_CD days_NNS of_IN incubation_NN if_IN the_DT broth_NN is_VBZ shaken_VBN or_CC a_DT minimum_NN of_IN 10_CD days_NNS in_IN unshaken_JJ broth_NN to_TO produce_VB visible_JJ growth_NN ._SENT In_IN static_JJ thioglycollate_NN broth_NN ,_, growth_NN is_VBZ seen_VBN first_RB as_IN a_DT dense_JJ band_NN near_IN the_DT top_NN which_WDT diffuses_VBZ throughout_IN the_DT broth_NN as_IN growth_NN progresses_NNS ._SENT The_DT most_RBS widely_RB used_VBN synthetic_JJ medium_NN used_VBN for_IN the_DT growth_NN of_IN tularemia_NN was_VBD devised_VBN by_IN Chamberlain_NP ._SENT However_RB ,_, defined_VBD media_NNS are_VBP not_RB used_VBN for_IN routine_JJ diagnosis_NN of_IN tularemia_NN ._SENT Direct_JJ isolation_NN of_IN bacteria_NNS is_VBZ frequently_RB achieved_VBN from_IN ulcer_NN scrapings_NNS ,_, lymph_NN node_NN biopsies_NNS ,_, or_CC sputum_NN ._SENT The_DT organism_NN is_VBZ rarely_RB cultured_VBN directly_RB from_IN blood_NN ,_, although_IN this_DT is_VBZ becoming_VBG feasible_JJ with_IN the_DT development_NN of_IN sensitive_JJ blood_NN culture_NN systems_NNS ._SENT The_DT isolation_NN of_IN bacteria_NNS from_IN urine_NN or_CC feces_NN is_VBZ not_RB frequently_RB done_VBN ,_, but_CC antigen_NN detection_NN in_IN urine_NN and_CC RNA_NP hybridization_NN of_IN wound_NN specimens_NNS have_VBP been_VBN reported_VBN ._SENT In_IN stained_VBN tissue_NN sections_NNS ,_, bacteria_NNS may_MD be_VB found_VBN both_DT intra-_NN and_CC extracellularly_RB ._SENT Enzyme-linked_JJ immunosorbent_JJ assay_NN (ELISA)-based_JJ tests_NNS can_MD also_RB be_VB used_VBN to_TO detect_VB the_DT bacteria_NNS in_IN clinical_JJ samples_NNS ._SENT For_IN example_NN ,_, a_DT capture_NN ELISA_NP using_VBG monoclonal_NN antibodies_NNS against_IN F._NP tularensis_NN lipopolysaccharide_NN (_( LPS_NP )_) recognized_VBD all_DT strains_NNS of_IN F._NP tularensis_NN tested_VBD other_JJ than_IN those_DT of_IN subspecies_NN novicida_NN ,_, with_IN no_DT cross-reactivity_NN with_IN other_JJ bacterial_JJ species_NNS tested_VBD ._SENT The_DT sensitivity_NN was_VBD 103_CD CFU/ml_NN in_IN phosphate-buffered_JJ saline_NN (_( PBS_NP )_) and_CC 104_CD CFU/ml_NN in_IN spiked_JJ human_JJ sera_NN ._SENT An_DT immunochromatographic_JJ hand-held_JJ assay_NN has_VBZ also_RB been_VBN developed_VBN based_VBN on_IN a_DT polyclonal_JJ and_CC a_DT monoclonal_NN antibody_NN to_TO LPS_NP of_IN F._NP tularensis_NN LVS_NP ;_: the_DT detection_NN limits_VBZ of_IN this_DT assay_NN were_VBD 106_CD CFU/ml_NP PBS_NP and_CC 106_CD to_TO 107_CD CFU/ml_NN in_IN spiked_JJ human_JJ sera_NN ._SENT This_DT assay_NN is_VBZ principally_RB designed_VBN for_IN field_NN use_NN ,_, being_VBG compact_JJ and_CC easy_JJ to_TO use_VB and_CC giving_VBG results_NNS in_IN 15_CD min_NN ,_, but_CC the_DT relatively_RB low_JJ sensitivity_NN means_VBZ that_IN a_DT negative_JJ result_NN does_VBZ not_RB exclude_VB tularemia_NN ._SENT Because_IN of_IN the_DT difficulty_NN in_IN culturing_VBG F._NP tularensis_NN ,_, most_JJS cases_NNS of_IN tularemia_NN are_VBP diagnosed_VBN on_IN the_DT basis_NN of_IN clinical_JJ picture_NN and/or_CC serology_NN ._SENT Serological_JJ tests_NNS for_IN the_DT diagnosis_NN of_IN F._NP tularensis_NN infection_NN are_VBP attractive_JJ because_IN diagnostic_JJ work_NN involving_VBG culture_NN procedures_NNS carries_VBZ a_DT risk_NN of_IN infection_NN for_IN nonvaccinated_JJ laboratory_NN staff_NN ._SENT The_DT diagnosis_NN of_IN human_JJ cases_NNS of_IN tularemia_NN is_VBZ usually_RB confirmed_VBN by_IN the_DT demonstration_NN of_IN an_DT antibody_NN response_NN to_TO F._NP tularensis_NN ,_, which_WDT occurs_VBZ about_RB 2_CD weeks_NNS after_IN the_DT onset_NN of_IN the_DT disease_NN ._SENT The_DT detection_NN of_IN serum_NN antibodies_NNS is_VBZ most_RBS frequently_RB achieved_VBN by_IN agglutination_NN or_CC an_DT ELISA_NP ._SENT A_DT latex_NN agglutination_NN test_NN commercially_RB available_JJ from_IN BBL_NP (_( Becton_NP Dickinson_NP ,_, Franklin_NP Lakes_NP ,_, N.J._NP )_) has_VBZ been_VBN used_VBN by_IN some_DT workers_NNS to_TO identify_VB individuals_NNS with_IN antibodies_NNS to_TO F._NP tularensis_NN :_: reactions_NNS at_IN dilutions_NNS greater_JJR than_IN 1:20_CD are_VBP considered_VBN specific_JJ and_CC significant_JJ ._SENT Using_VBG this_DT test_NN ,_, 2_CD %_NN of_IN trappers_NNS in_IN Quebec_NP were_VBD found_VBN to_TO be_VB seropositive_JJ (_( at_IN serum_NN dilutions_NNS of_IN 1:20_CD to_TO 1:2,048_CD )_) for_IN F._NP tularensis_NN ._SENT The_DT only_JJ association_NN between_IN this_DT population_NN and_CC the_DT development_NN of_IN antibodies_NNS appeared_VBD to_TO be_VB the_DT trapping_VBG of_IN muskrats_NNS ._SENT Commercially_RB available_JJ antigens_NNS can_MD also_RB be_VB used_VBN with_IN standard_JJ tube_NN agglutination_NN tests_NNS ._SENT A_DT fourfold_JJ increase_NN during_IN illness_NN or_CC a_DT single_JJ titer_NN of_IN 1:160_CD or_CC greater_JJR is_VBZ considered_VBN diagnostic_JJ ._SENT However_RB ,_, while_IN serological_JJ tests_NNS are_VBP frequently_RB used_VBN for_IN diagnosis_NN ,_, strains_NNS of_IN F._NP tularensis_NNS have_VBP occasionally_RB been_VBN isolated_VBN which_WDT fail_VBP to_TO agglutinate_VB commercially_RB available_JJ F._NP tularensis_NN antigens_NNS ._SENT A_DT range_NN of_IN PCR-based_JJ assays_NNS have_VBP been_VBN reported_VBN for_IN the_DT detection_NN of_IN F._NP tularensis_NN or_CC for_IN the_DT diagnosis_NN of_IN tularemia_NN ._SENT These_DT PCR_NP assays_NNS have_VBP all_RB used_VBN primers_NNS directed_VBN against_IN genes_NNS encoding_VBG outer_JJ membrane_NN proteins_NNS such_JJ as_IN fopA_NN or_CC the_DT 17-kDa_NP outer_JJ membrane_NN lipoprotein_NN ._SENT These_DT PCR_NP assays_NNS offer_VBP high_JJ specificity_NN ,_, failing_VBG to_TO generate_VB an_DT amplicon_NN using_VBG template_NN DNA_NN from_IN a_DT range_NN of_IN other_JJ bacterial_JJ pathogens_NNS ._SENT When_WRB used_VBN with_IN pure_JJ cultures_NNS of_IN F._NP tularensis_NN as_IN the_DT source_NN of_IN template_NN DNA_NN ,_, the_DT assays_NNS also_RB offer_VBP high_JJ levels_NNS of_IN sensitivity_NN ._SENT The_DT PCR_NP assay_NN reported_VBD by_IN Grunow_NP et_FW al._FW allowed_VBD the_DT detection_NN of_IN 102_CD CFU/ml_NN in_IN PBS_NP ,_, and_CC the_DT use_NN of_IN a_DT nested_VBN PCR_NP assay_NN allowed_VBD the_DT detection_NN of_IN 1_CD CFU_NP of_IN F._NP tularensis_NN ._SENT However_RB ,_, samples_NNS such_JJ as_IN blood_NN contain_VBP compounds_NNS capable_JJ of_IN inhibiting_VBG the_DT PCR_NP ,_, making_VBG detection_NN of_IN such_JJ low_JJ levels_NNS of_IN bacteria_NNS in_IN clinical_JJ samples_NNS impossible_JJ ._SENT In_IN addition_NN ,_, blood_NN samples_NNS invariably_RB require_VBP some_DT form_NN of_IN processing_VBG to_TO allow_VB high-sensitivity_NN PCR_NP tests_VBZ to_TO be_VB carried_VBN out_RP ._SENT Nevertheless_RB ,_, the_DT PCR_NP assay_NN reported_VBD by_IN Grunow_NP et_FW al._FW was_VBD shown_VBN to_TO detect_VB 103_CD to_TO 104_CD CFU/ml_NN of_IN spiked_JJ serum_NN ,_, while_IN the_DT nested_VBN PCR_NP assay_NN reported_VBD by_IN Fulop_NP et_FW al._FW was_VBD able_JJ to_TO detect_VB 102_CD CFU/ml_NN of_IN spiked_JJ blood_NN ._SENT Even_RB in_IN their_PP$ current_JJ forms_NNS ,_, these_DT assays_NNS do_VBP appear_VB to_TO offer_VB advantages_NNS over_IN the_DT direct_JJ culture_NN of_IN bacteria_NNS ._SENT In_IN mice_NNS ,_, 83_CD %_NN of_IN blood_NN samples_NNS taken_VBN 24_CD h_NN after_IN experimental_JJ infection_NN were_VBD positive_JJ by_IN PCR_NP ,_, while_IN bacteria_NNS could_MD be_VB cultured_VBN from_IN only_RB 48_CD %_NN of_IN the_DT samples_NNS ._SENT This_DT advantage_NN appears_VBZ to_TO extend_VB to_TO clinical_JJ samples_NNS :_: in_IN a_DT study_NN with_IN swab_NN samples_NNS taken_VBN from_IN the_DT lesion_NN site_NN in_IN 40_CD human_JJ cases_NNS of_IN ulceroglandular_JJ tularemia_NN ,_, a_DT PCR_NP assay_NN was_VBD positive_JJ for_IN 73_CD %_NN of_IN the_DT samples_NNS ,_, whereas_IN bacteria_NNS were_VBD cultured_VBN from_IN only_RB 25_CD %_NN of_IN the_DT samples_NNS ._SENT Moreover_RB ,_, PCR_NP identified_VBD F._NP tularensis_NN in_IN one_CD sample_NN which_WDT had_VBD not_RB been_VBN identified_VBN by_IN culture_NN or_CC serology_NN in_IN a_DT parallel_JJ study_NN ._SENT Subsequently_RB ,_, a_DT number_NN of_IN other_JJ workers_NNS have_VBP reported_VBN the_DT use_NN of_IN PCR_NP assays_NNS for_IN the_DT diagnosis_NN of_IN tularemia_NN or_CC for_IN the_DT analysis_NN of_IN environmental_JJ samples_NNS ._SENT These_DT PCR-based_JJ tests_NNS might_MD also_RB be_VB safer_JJR than_IN tests_NNS which_WDT involve_VBP the_DT culture_NN of_IN bacteria_NNS ._SENT Improved_VBN methods_NNS for_IN the_DT isolation_NN and_CC processing_NN of_IN tissue_NN or_CC blood_NN samples_NNS and_CC for_IN the_DT transport_NN of_IN samples_NNS to_TO the_DT laboratory_NN might_MD further_RBR improve_VB the_DT sensitivity_NN and_CC utility_NN of_IN the_DT PCR_NP test_NN ._SENT Indeed_RB ,_, a_DT specially_RB formulated_VBN filter_NN paper_NN designed_VBN for_IN sample_NN collection_NN has_VBZ been_VBN proposed_VBN for_IN the_DT rapid_JJ preparation_NN of_IN template_NN DNA_NN from_IN clinical_JJ or_CC field-collected_JJ tick_NN vectors_NNS ._SENT When_WRB linked_VBN with_IN a_DT TaqMan_NP 5_CD '_POS nuclease_NN assay_NN or_CC a_DT PCR-enzyme_NP immunoassay_NN ,_, sensitivities_NNS of_IN <100_NP CFU_NP were_VBD reported_VBN ._SENT While_IN PCR_NP assays_NNS have_VBP allowed_VBN the_DT rapid_JJ detection_NN of_IN a_DT range_NN of_IN F._NP tularensis_NN strains_NNS ,_, other_JJ workers_NNS have_VBP developed_VBN molecular_JJ methods_NNS to_TO discriminate_VB between_IN Francisella_NP strains_NNS ._SENT PCR-based_JJ methods_NNS have_VBP been_VBN evaluated_VBN for_IN their_PP$ potential_NN to_TO identify_VB F._NP tularensis_NN and_CC discriminate_JJ between_IN the_DT different_JJ subspecies_NN ._SENT Long_JJ random_JJ sequence_NN oligonucleotide_NN primers_NNS and_CC primers_NNS specific_JJ for_IN repetitive_JJ extragenic_JJ palindromic_JJ (_( REP_JJ )_) sequences_NNS and_CC enterobacterial_JJ repetitive_JJ intragenic_JJ consensus_NN (_( ERIC_JJ )_) sequences_NNS were_VBD evaluated_VBN ._SENT REP-PCR_NP has_VBZ been_VBN applied_VBN to_TO specifically_RB identifying_VBG strains_NNS of_IN F._NP tularensis_NN subsp_NN ._SENT novicida_NN ,_, but_CC patterns_NNS from_IN subspecies_NN holarctica_NN and_CC tularensis_NN were_VBD found_VBN to_TO be_VB similar_JJ ._SENT A_DT one-base_JJ difference_NN in_IN the_DT 16S_JJ rRNA_NN sequences_NNS of_IN F._NP tularensis_NN subsp_NN ._SENT tularensis_NN and_CC F._NP tularensis_NN subsp_NN ._SENT holarctica_NP has_VBZ been_VBN demonstrated_VBN ,_, and_CC on_IN this_DT basis_NN a_DT PCR_NP has_VBZ been_VBN developed_VBN which_WDT can_MD differentiate_VB the_DT two_CD subspecies_NN ._SENT In_IN one_CD study_NN ,_, PCR_NP analyses_NNS based_VBN on_IN the_DT use_NN of_IN ERIC_NP ,_, REP_NN or_CC long_JJ random_JJ sequence_NN primers_NNS yielded_VBD reproducible_JJ banding_VBG patterns_NNS of_IN similar_JJ complexity_NN and_CC allowed_VBN differentiation_NN of_IN strains_NNS at_IN the_DT subspecies_NN level_NN ,_, but_CC the_DT methods_NNS investigated_VBN do_VBP not_RB meet_VB the_DT criteria_NNS for_IN typing_VBG of_IN individual_JJ isolates_NNS ._SENT More_RBR recent_JJ studies_NNS suggest_VBP that_IN PCR_NP amplification_NN of_IN tandem_JJ repeat_NN regions_NNS may_MD be_VB highly_RB discriminatory_JJ and_CC a_DT useful_JJ tool_NN in_IN strain_NN typing_VBG ._SENT A_DT specific_JJ PCR_NP has_VBZ been_VBN developed_VBN which_WDT produces_VBZ amplicons_NNS of_IN different_JJ lengths_NNS (_( target_NN unknown_NN )_) ,_, which_WDT has_VBZ been_VBN used_VBN in_IN combination_NN with_IN the_DT 17-kDa_NP lipoprotein_NN PCR_NP and_CC can_MD distinguish_VB F._NP tularensis_NN subsp_NN ._SENT holarctica_NN from_IN strains_NNS of_IN other_JJ F._NP tularensis_NN subspecies_NN ._SENT Tularemia_NN in_IN humans_NNS can_MD occur_VB in_IN several_JJ forms_NNS ,_, depending_VBG to_TO a_DT large_JJ extent_NN on_IN the_DT route_NN of_IN entry_NN of_IN the_DT bacterium_NN into_IN the_DT body_NN ._SENT Although_IN tularemia_NN can_MD be_VB a_DT severely_RB debilitating_JJ disease_NN ,_, especially_RB when_WRB caused_VBN by_IN F._NP tularensis_NN subsp_NN ._SENT tularensis_NN ,_, many_JJ cases_NNS of_IN disease_NN caused_VBN by_IN lower-virulence_NN strains_NNS are_VBP undiagnosed_JJ ._SENT The_DT most_RBS common_JJ form_NN of_IN the_DT disease_NN is_VBZ ulceroglandular_JJ tularemia_NN ,_, which_WDT usually_RB occurs_VBZ as_IN a_DT consequence_NN of_IN a_DT bite_NN from_IN an_DT arthropod_NN vector_NN which_WDT has_VBZ previously_RB fed_VBN on_IN an_DT infected_JJ animal_NN ._SENT Some_DT cases_NNS of_IN ulceroglandular_JJ tularemia_NN occur_VBP in_IN hunters_NNS and_CC trappers_NNS as_IN a_DT consequence_NN of_IN the_DT handling_NN of_IN infected_JJ meat_NN ,_, with_IN infection_NN via_IN cuts_NNS or_CC abrasions_NNS ._SENT After_IN an_DT incubation_NN period_NN of_IN typically_RB 3_CD to_TO 6_CD days_NNS ,_, the_DT patient_NN experiences_VBZ the_DT sudden_JJ onset_NN of_IN flu-like_JJ symptoms_NNS ,_, especially_RB chills_NNS ,_, fever_NN ,_, headache_NN ,_, and_CC generalized_VBN aches_NNS ._SENT An_DT ulcer_NN ,_, which_WDT can_MD persist_VB for_IN several_JJ months_NNS ,_, forms_NNS at_IN the_DT site_NN of_IN infection_NN ,_, usually_RB on_IN the_DT lower_JJR limbs_NNS in_IN the_DT cases_NNS of_IN tick-borne_JJ disease_NN (_( a_DT disease_NN with_IN similar_JJ symptoms_NNS but_CC without_IN the_DT appearance_NN of_IN an_DT ulcer_NN is_VBZ termed_VBN glandular_JJ tularemia_NN )_) ._SENT Bacteria_NNS are_VBP disseminated_VBN from_IN this_DT site_NN via_IN the_DT lymphatic_JJ system_NN to_TO regional_JJ lymph_NN nodes_NNS ._SENT The_DT enlargement_NN of_IN these_DT lymph_NN nodes_NNS often_RB resembles_VBZ the_DT classical_JJ bubo_NN associated_VBN with_IN bubonic_JJ plague_NN ._SENT From_IN this_DT site_NN ,_, bacteria_NNS may_MD be_VB disseminated_VBN to_TO other_JJ tissues_NNS such_JJ as_IN the_DT spleen_NN ,_, liver_NN ,_, lungs_NNS ,_, kidneys_NNS ,_, intestine_NN ,_, central_JJ nervous_JJ system_NN ,_, and_CC skeletal_JJ muscles_NNS ._SENT However_RB ,_, the_DT bacteremic_JJ phase_NN of_IN the_DT infection_NN is_VBZ transient_JJ and_CC occurs_VBZ relatively_RB early_RB in_IN the_DT infection_NN process_NN ._SENT Recovery_NN from_IN the_DT disease_NN can_MD be_VB protracted_JJ ,_, but_CC the_DT ulceroglandular_JJ form_NN of_IN tularemia_NN is_VBZ rarely_RB fatal_JJ (_( the_DT mortality_NN rate_NN from_IN ulceroglandular_JJ tularemia_NN is_VBZ typically_RB less_JJR than_IN 3_CD %_NN )_) ._SENT Even_RB without_IN treatment_NN ,_, ulceroglandular_JJ and_CC glandular_JJ tularemia_NN are_VBP rarely_RB fatal_JJ ,_, but_CC may_MD take_VB a_DT significant_JJ length_NN of_IN time_NN to_TO resolve_VB ._SENT On_IN the_DT other_JJ hand_NN ,_, an_DT acute_JJ form_NN of_IN the_DT disease_NN produced_VBN by_IN F._NP tularensis_NN subsp_NN ._SENT tularensis_NN ,_, typhoidal_JJ tularemia_NN ,_, is_VBZ typified_VBN as_IN a_DT septicemia_NN without_IN lymphadenopathy_NN or_CC the_DT appearance_NN of_IN an_DT ulcer_NN and_CC carries_VBZ a_DT mortality_NN rate_NN of_IN 30_CD to_TO 60_CD %_NN ._SENT In_IN addition_NN to_TO the_DT symptoms_NNS described_VBD above_RB ,_, the_DT patient_NN may_MD be_VB delirious_JJ and_CC shock_NN may_MD develop_VB ._SENT A_DT rare_JJ variation_NN of_IN ulceroglandular_JJ disease_NN is_VBZ oculoglandular_JJ tularemia_NN ,_, where_WRB the_DT conjunctiva_NN is_VBZ the_DT initial_JJ site_NN of_IN infection_NN ,_, usually_RB as_IN a_DT result_NN of_IN the_DT transfer_NN of_IN bacteria_NNS on_IN the_DT fingertips_NNS ._SENT The_DT disease_NN is_VBZ marked_VBN by_IN the_DT appearance_NN of_IN ulcers_NNS and_CC nodules_NNS on_IN the_DT conjunctiva_NN ,_, and_CC without_IN treatment_NN the_DT infection_NN spreads_VBZ to_TO the_DT local_JJ lymph_NN nodes_NNS The_DT ingestion_NN of_IN infected_JJ foodstuffs_NNS or_CC of_IN bacteria_NNS in_IN drinking_NN water_NN can_MD result_VB in_IN oropharyngeal_JJ or_CC gastrointestinal_JJ tularemia_NN ,_, depending_VBG on_IN the_DT site_NN of_IN colonization_NN of_IN host_NN tissues_NNS ._SENT The_DT former_JJ is_VBZ often_RB described_VBN as_IN a_DT painful_JJ sore_JJ throat_NN with_IN enlargement_NN of_IN the_DT tonsils_NNS and_CC the_DT formation_NN of_IN a_DT yellow-white_JJ pseudomembrane_NN ._SENT This_DT is_VBZ most_RBS often_RB accompanied_VBN by_IN swollen_JJ cervical_JJ lymph_NN nodes_NNS ._SENT Depending_VBG on_IN the_DT infecting_VBG dose_NN ,_, gastrointestinal_JJ tularemia_NN ranges_NNS from_IN mild_JJ but_CC persistent_JJ diarrhea_NN to_TO an_DT acute_JJ fatal_JJ disease_NN with_IN extensive_JJ ulceration_NN of_IN the_DT bowel_NN ._SENT Probably_RB the_DT most_RBS acute_JJ form_NN is_VBZ disease_NN is_VBZ associated_VBN with_IN the_DT inhalation_NN of_IN bacteria_NNS ,_, although_IN pneumonic_JJ disease_NN can_MD also_RB occur_VB as_IN a_DT complication_NN of_IN ulceroglandular_JJ ,_, glandular_JJ ,_, oculoglandular_JJ ,_, or_CC oropharyngeal_JJ tularemia_NN ._SENT The_DT clinical_JJ and_CC roentgenographic_JJ features_NNS of_IN pneumonic_JJ tularemia_NN are_VBP quite_RB variable_JJ ,_, making_VBG diagnosis_NN difficult_JJ ._SENT On_IN occasion_NN ,_, pneumonic_JJ tularemia_NN may_MD even_RB occur_VB without_IN any_DT overt_JJ signs_NNS of_IN pneumonia_NN ._SENT The_DT occasional_JJ naturally_RB occurring_VBG cases_NNS of_IN inhalation_NN tularemia_NN often_RB arise_VBP from_IN farming_VBG activities_NNS which_WDT involve_VBP the_DT handling_NN (_( and_CC the_DT subsequent_JJ generation_NN of_IN dusts_NNS )_) of_IN hay_NN which_WDT has_VBZ previously_RB been_VBN the_DT site_NN of_IN residence_NN of_IN infected_JJ rodents_NNS ._SENT ._SENT FIG._NN 4_CD ._SENT |_SYM Enlarged_JJ lymph_NN node_NN in_IN a_DT tularemia_NN patient_NN ._SENT Enlarged_JJ lymph_NN node_NN in_IN a_DT tularemia_NN patient_NN ._SENT The_DT pathogenesis_NN of_IN the_DT LVS_NP strain_NN in_IN mice_NNS has_VBZ been_VBN used_VBN as_IN a_DT model_NN to_TO study_VB the_DT behavior_NN of_IN intracellular_JJ pathogens_NNS ._SENT A_DT study_NN published_VBN in_IN 1946_CD compared_VBN the_DT sensitivities_NNS of_IN various_JJ animal_NN models_NNS to_TO strain_VB Schu_NP S4_NP ._SENT It_PP was_VBD shown_VBN that_IN Schu_NP S4_NP was_VBD fully_RB virulent_JJ in_IN the_DT mouse_NN ,_, guinea_NN pig_NN ,_, rabbit_NN ,_, hamster_NN ,_, and_CC cotton_NN rat_NN ._SENT The_DT last_JJ was_VBD shown_VBN to_TO have_VB a_DT high_JJ degree_NN of_IN individual_JJ variation_NN in_IN response_NN to_TO Schu_NP S4_NP ,_, and_CC accordingly_RB this_DT model_NN has_VBZ received_VBN little_JJ attention_NN ._SENT Strains_NNS from_IN all_DT of_IN the_DT subspecies_NN of_IN F._NP tularensis_NNS are_VBP reported_VBN to_TO be_VB virulent_JJ in_IN the_DT murine_NN and_CC guinea_NN pig_NN models_NNS of_IN disease_NN ,_, but_CC only_RB strains_NNS of_IN F._NP tularensis_NN subsp_NN ._SENT tularensis_NNS are_VBP considered_VBN virulent_JJ in_IN the_DT rabbit_NN model_NN of_IN disease_NN ._SENT Most_JJS studies_NNS on_IN the_DT behavior_NN of_IN F._NP tularensis_NN in_IN vivo_RB rely_VB on_IN the_DT infection_NN of_IN inbred_JJ mice_NNS ,_, and_CC this_DT murine_JJ tularemia_NN system_NN has_VBZ become_VBN a_DT model_NN to_TO study_VB the_DT behavior_NN of_IN intracellular_JJ pathogens_NNS ._SENT There_EX is_VBZ some_DT evidence_NN that_IN strains_NNS with_IN differing_VBG virulence_NN can_MD be_VB differentiated_VBN by_IN using_VBG this_DT model_NN ._SENT For_IN example_NN ,_, strain_NN Schu_NP S4_NP is_VBZ fully_RB virulent_JJ regardless_RB of_IN the_DT route_NN of_IN administration_NN ._SENT However_RB ,_, the_DT virulence_NN of_IN LVS_NP has_VBZ been_VBN shown_VBN to_TO be_VB dependent_JJ on_IN the_DT route_NN of_IN delivery_NN ;_: LVS_NP is_VBZ fully_RB virulent_JJ in_IN the_DT mouse_NN ,_, with_IN a_DT median_JJ lethal_JJ dose_NN of_IN <10_JJ CFU_NP when_WRB delivered_VBN intraperitoneally_RB ,_, but_CC is_VBZ attenuated_VBN in_IN the_DT mouse_NN when_WRB delivered_VBN intradermally_RB ._SENT TABLE_NN 2_CD |_SYM Virulence_NN of_IN F._NP tularensis_NN biotypes_NNS In_IN typical_JJ human_JJ ulceroglandular_JJ tularemia_NN ,_, a_DT skin_NN lesion_NN first_RB appears_VBZ at_IN the_DT site_NN of_IN infection_NN 3_CD to_TO 5_CD days_NNS after_IN infective_JJ exposure_NN ._SENT During_IN this_DT initial_JJ phase_NN ,_, T_NN cells_NNS appear_VBP to_TO play_VB little_JJ role_NN in_IN combating_VBG infection_NN ._SENT The_DT systemic_JJ administration_NN of_IN tumor_NN necrosis_NN factor_NN or_CC gamma_NN interferon_NN (_( IFN-gamma_NP )_) is_VBZ capable_JJ of_IN reducing_VBG the_DT severity_NN of_IN tularemia_NN ,_, indicating_VBG the_DT key_JJ role_NN these_DT cytokines_NNS play_VBP in_IN response_NN to_TO infection_NN ._SENT During_IN the_DT early_JJ stages_NNS of_IN disease_NN ,_, studies_NNS with_IN other_JJ pathogens_NNS have_VBP suggested_VBN that_IN keratinocytes_NNS are_VBP a_DT likely_JJ source_NN of_IN tumor_NN necrosis_NN factor_NN ,_, while_IN natural_JJ killer_NN (_( NK_JJ )_) cells_NNS may_MD produce_VB IFN-gamma_NP ._SENT A_DT transient_JJ bacteremia_NN occurs_VBZ ,_, during_IN which_WDT the_DT pathogen_NN must_MD resist_VB lysis_NN by_IN complement_NN ._SENT Protection_NP appears_VBZ to_TO be_VB due_JJ to_TO the_DT presence_NN of_IN capsule_NN ,_, as_IN a_DT nonencapsulated_JJ mutant_NN was_VBD susceptible_JJ to_TO killing_VBG by_IN nonimmune_JJ serum_NN ._SENT The_DT bacteremic_JJ phase_NN allows_VBZ the_DT organism_NN to_TO be_VB seeded_VBN throughout_IN the_DT body_NN ,_, infecting_VBG all_DT reticuloendothelial_JJ tissues_NNS ._SENT Within_IN days_NNS ,_, a_DT wide_JJ range_NN of_IN cytokines_NNS are_VBP expressed_VBN in_IN the_DT reticuloendothelial_JJ tissues_NNS ._SENT In_IN the_DT liver_NN ,_, for_IN example_NN ,_, the_DT bacteria_NNS are_VBP able_JJ to_TO invade_VB and_CC multiply_VB within_IN hepatocytes_NNS ,_, and_CC tumor_NN necrosis_NN factor_NN alpha_NN ,_, interleukin-10_NN ,_, interleukin-12_NN ,_, and_CC IFN-gamma_NP are_VBP produced_VBN within_IN 48_CD h_NN ._SENT However_RB ,_, although_IN this_DT cytokine_NN response_NN ,_, assumed_VBD to_TO evoke_VB the_DT expansion_NN of_IN a_DT protective_JJ Th1_JJ response_NN ,_, was_VBD capable_JJ of_IN mounting_VBG a_DT defense_NN against_IN the_DT LVS_NP strain_NN ,_, it_PP was_VBD unable_JJ to_TO prevent_VB a_DT more_RBR virulent_JJ strain_NN from_IN mounting_VBG a_DT lethal_JJ infection_NN in_IN mice_NNS ._SENT Infection_NN also_RB induces_VBZ a_DT stress_NN response_NN in_IN infected_JJ host_NN cells_NNS ;_: hsp72_NN was_VBD induced_VBN in_IN peritoneal_JJ exudate_NN cells_NNS of_IN infected_JJ mice_NNS which_WDT were_VBD susceptible_JJ to_TO tularemia_NN for_IN 3_CD days_NNS following_VBG infection_NN ._SENT Later_RBR during_IN infection_NN ,_, T_NN cells_NNS appear_VBP to_TO play_VB a_DT major_JJ role_NN in_IN protection_NN ._SENT Mice_NNS depleted_VBN of_IN CD4+_NP and/or_CC CD8+_NP T_NN cells_NNS were_VBD capable_JJ of_IN controlling_VBG a_DT primary_JJ LVS_NP infection_NN ,_, but_CC were_VBD not_RB able_JJ to_TO resolve_VB it_PP ,_, indicating_VBG a_DT scenario_NN of_IN complex_JJ interactions_NNS of_IN different_JJ cell_NN types_NNS in_IN primary_JJ infection_NN ._SENT Studies_NNS with_IN knockout_JJ mice_NNS infected_VBN with_IN strain_NN LVS_NNS confirm_VBP these_DT observations_NNS ,_, but_CC CD4-_NP ,_, beta2-microglobulin-deficient/CD8-_NN ,_, and_CC gammadelta_NN T-cell_NN receptor-negative_NN mice_NNS were_VBD all_RB able_JJ to_TO resolve_VB an_DT infection_NN ._SENT However_RB ,_, alphabeta_NN T-cell_NN receptor-negative_JJ knockout_NN mice_NNS succumbed_VBN to_TO infection_NN ,_, indicating_VBG that_IN while_IN either_DT CD4_NP or_CC CD8_NP T_NN cells_NNS are_VBP individually_RB sufficient_JJ to_TO resolve_VB infection_NN with_IN strain_NN LVS_NP ,_, alphabeta_NN T-cell_NN receptor_NN cells_NNS are_VBP required_VBN for_IN protection_NN ._SENT In_IN mice_NNS challenged_VBN with_IN a_DT high-virulence_NN strain_NN (_( Schu_NP S4_NP )_) ,_, both_CC CD4_NP and_CC CD8_NP T_NN cells_NNS appeared_VBD to_TO play_VB key_JJ roles_NNS in_IN controlling_VBG disease_NN ._SENT Circulating_VBG gammadelta_NN T_NN cells_NNS are_VBP well_RB known_VBN for_IN controlling_VBG bacterial_JJ intracellular_JJ infections_NNS ;_: for_IN example_NN ,_, they_PP are_VBP essential_JJ in_IN controlling_VBG Listeria_NN monocytogenes_NNS infections_NNS ._SENT A_DT significant_JJ expansion_NN in_IN the_DT Vgamma9Vdelta2_NP T-cell_NN subpopulation_NN was_VBD observed_VBN in_IN a_DT Japanese_JJ patient_NN with_IN tularemia_NN ._SENT This_DT effect_NN was_VBD subsequently_RB shown_VBN to_TO occur_VB within_IN a_DT week_NN of_IN infection_NN ,_, but_CC could_MD persist_VB for_IN over_IN a_DT year_NN ._SENT This_DT response_NN appears_VBZ to_TO be_VB due_JJ to_TO exposure_NN to_TO phosphoantigens_NNS expressed_VBN by_IN F._NP tularensis_NN in_IN vivo_RB ._SENT Phosphoantigens_NNS are_VBP powerful_JJ stimu_NN 